Bruker Corporation Free Cash Flow 2009–2025
Bruker Corporation reported $43.30M of free cash flow for fiscal 2025. That was 68.2% lower than fiscal 2024. Compared with fiscal 2020, the change was -81.6%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $43.30M | -68.2% |
| FY 2024 | $136.00M | -44.1% |
| FY 2023 | $243.20M | +67.5% |
| FY 2022 | $145.20M | -23.7% |
| FY 2021 | $190.40M | -19.0% |
| FY 2020 | $235.00M | +67.4% |
| FY 2019 | $140.40M | -26.3% |
| FY 2018 | $190.50M | +72.1% |
| FY 2017 | $110.70M | +18.1% |
| FY 2016 | $93.70M | -51.9% |
| FY 2015 | $195.00M | +142.2% |
| FY 2014 | $80.50M | -15.0% |
| FY 2013 | $94.70M | +57.0% |
| FY 2012 | $60.30M | +131.0% |
| FY 2011 | $26.10M | -79.0% |
| FY 2010 | $124.20M | -7.0% |
| FY 2009 | $133.50M | — |
Source: Bruker Corporation SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BRKR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Bruker Corporation reported $43.30M of free cash flow for fiscal 2025. That was 68.2% lower than fiscal 2024. Compared with fiscal 2020, the change was -81.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Bruker Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBruker Corporation — frequently asked questions
What is Bruker Corporation's free cash flow?
Bruker Corporation (BRKR) reported free cash flow of $43.30M for fiscal year 2025, per its SEC filings.
How has Bruker Corporation's free cash flow changed over time?
Between fiscal 2009 and 2025, BRKR's free cash flow declined at roughly 6.8% per year (compound annual rate), from $133.50M to $43.30M.
Where does this data come from?
Figures are computed from Bruker Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.